2'-deoxyadenosine has been researched along with Severe Combined Immunodeficiency in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azzari, C; la Marca, G; Resti, M | 1 |
| Adams, S; Azzari, C; Bianchi, L; Canessa, C; de Martino, M; Della Bona, ML; Duse, M; Fairbanks, L; Funghini, S; Gaspar, BH; Giocaliere, E; Guerrini, R; Hershfield, M; la Marca, G; Lippi, F; Malvagia, S; Moriondo, M; Ombrone, D; Ragusa, G; Resti, M; Romano, F; Santisteban, I; Speckmann, C; Valleriani, C; Villanelli, F | 1 |
| Blackburn, MR; Datta, SK; Kellems, RE | 1 |
| Ariga, T; Arredondo-Vega, FX; Hershfield, MS; Kobayashi, K; Oda, N; Sakiyama, Y; Sanstisteban, I; Shioda, M; Terada, K; Ueno, H | 1 |
| Apasov, SG; Blackburn, MR; Kellems, RE; Sitkovsky, MV; Smith, PT | 1 |
| Aldrich, MB; Blackburn, MR; Datta, SK; Kellems, RE | 1 |
1 review(s) available for 2'-deoxyadenosine and Severe Combined Immunodeficiency
| Article | Year |
|---|---|
Adenosine deaminase-deficient mice: models for the study of lymphocyte development and adenosine signaling.
Topics: Adenosine; Adenosine Deaminase; Adenosylhomocysteinase; Animals; Deoxyadenosines; Disease Models, Animal; Humans; Hydrolases; Lymphocytes; Mice; Mice, Knockout; Receptor, Adenosine A3; Receptors, Purinergic P1; Severe Combined Immunodeficiency; Signal Transduction | 2000 |
5 other study(ies) available for 2'-deoxyadenosine and Severe Combined Immunodeficiency
| Article | Year |
|---|---|
Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry.
Topics: Adenosine; Adenosine Deaminase; Agammaglobulinemia; Blood Chemical Analysis; Case-Control Studies; Child; Child, Preschool; Costs and Cost Analysis; Deoxyadenosines; Female; Humans; Infant; Infant, Newborn; Italy; Male; Neonatal Screening; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity; Severe Combined Immunodeficiency; Tandem Mass Spectrometry | 2011 |
Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.
Topics: Adenosine Deaminase; Agammaglobulinemia; Deoxyadenosines; Enzyme Activation; Erythrocytes; Humans; Immunoglobulins; Immunophenotyping; Infant, Newborn; Lymphocyte Subsets; Receptors, Antigen, T-Cell; Retrospective Studies; Severe Combined Immunodeficiency; Tandem Mass Spectrometry | 2013 |
Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency.
Topics: Adenosine; Adenosine Deaminase; Adenosylhomocysteinase; Animals; Antigens, CD; Antigens, Differentiation; B-Lymphocytes; Bone and Bones; Deoxyadenosines; Genetic Engineering; Hydrolases; Kidney; Lung; Lymphocyte Count; Lymphopenia; Mice; Pulmonary Valve Insufficiency; Purine-Pyrimidine Metabolism, Inborn Errors; Research Design; Severe Combined Immunodeficiency; Spleen; T-Lymphocytes; Thymus Gland; Tissue Distribution | 1998 |
Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency.
Topics: Adenosine Deaminase; Alleles; Cell Line, Transformed; Cloning, Molecular; Deoxyadenosines; DNA Mutational Analysis; Enzyme Activation; Enzyme Stability; Escherichia coli; Female; Gene Expression Profiling; Genetic Carrier Screening; Hot Temperature; Humans; Infant; Male; Mutation, Missense; Pedigree; Severe Combined Immunodeficiency | 2001 |
Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.
Topics: Adenosine; Adenosine Deaminase; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; B-Lymphocytes; Calcium Signaling; Cell Differentiation; Cells, Cultured; Deoxyadenine Nucleotides; Deoxyadenosines; Gene Expression Regulation; Lectins, C-Type; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Knockout; Mice, SCID; Organ Specificity; Phosphorylation; Protein Processing, Post-Translational; Receptor-CD3 Complex, Antigen, T-Cell; Receptors, Interleukin-2; Severe Combined Immunodeficiency; Signal Transduction; Specific Pathogen-Free Organisms; Spleen; T-Lymphocytes; Thymus Gland | 2001 |